Performance of the Acoustic Based CADScor System in Coronary Artery Disease
Part of paid clinical trials in Oklahoma City, Oklahoma.
- Sponsor
- INTEGRIS Baptist Medical Center
- Study ID
- NCT06655779
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Angina (stable)
- Coronary Artery Disease
Eligibility Criteria
- Sex
- ALL
- Age
- 30 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Acoustic Detection of Blood Flow — DIAGNOSTIC_TESTSubject will have the acoustic device scoring performed prior to a Coronary CTA. No treatment decisions will be based upon the acoustic device score.
Study Details
The purpose of this study is to determine if the CAD Score, collected from the CADscore system, performs as well as the Coronary CTA in determining Coronary Artery Disease, in low to intermediate risk patients that are referred for coronary CTA.
Key Dates
- Start date
- Nov 30, 2024
- Status verified
- Oct 2024
- Primary completion
- Dec 31, 2025
- Completion
- Mar 31, 2026
Study Design
- Enrollment
- 200 participants (estimated)
Primary Outcome Measure
Primary Objective [ Time Frame: From enrollment through 1 year ]
Central Contacts
- Jill Fife, RN405-951-8607
- Linda Pitchford, RN, APRN405-949-3648
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| INTEGRIS Baptist Medical Center | Oklahoma City | Oklahoma | 73112 | Jon p Blaschke, MD |
Find similar trials in Oklahoma City, OK
By research site
Related Studies
- Efficacy and Saftey Study of 99mTc-ECDG in the Evaluation of Coronary Artery Disease (CAD)PHASE2 · Not Yet Recruiting · Cell>Point LLC · Oklahoma City, Oklahoma
- Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve ReplacementRecruiting · University of British Columbia · Huntsville, Alabama
- MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery LesionsRecruiting · Concept Medical Inc. · Birmingham, Alabama
- MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small VesselsRecruiting · Concept Medical Inc. · Gilbert, Arizona